Dr. med. Birger Kuhlmann

Hanover 30159

0 studies enrolling now · 1 studies all time

What they study most

HIV Infections

Studies at this site

• Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection — Stopped early